Steward Partners Investment Advisory, LLC Biotechnology

Steward Partners Investment Advisory, LLC

$10.9 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$112B	$19.9 Million 0.18% of portfolio	41,033	Q1 2025 Added 3.08%
VKTX Viking Therapeutics, Inc.	$2.19B	$5.75 Million 0.05% of portfolio	238,035	Q1 2025 Added 6.07%
NVO Novo Nordisk A S	$149B	$5.15 Million 0.05% of portfolio	74,234	Q1 2025 Reduced 42.45%
REGN Regeneron Pharmaceuticals, Inc.	$62.7B	$3.4 Million 0.03% of portfolio	5,368	Q1 2025 Added 16.01%
APLS Apellis Pharmaceuticals, Inc.	$1.8B	$2.67 Million 0.02% of portfolio	122,175	Q1 2025 Added 6.2%
RNA Avidity Biosciences, Inc.	$1.51B	$1.38 Million 0.01% of portfolio	46,750	Q1 2025 Reduced 3.51%
CORT Corcept Therapeutics Inc	$7.86B	$1.27 Million 0.01% of portfolio	11,112	Q1 2025 Reduced 9.29%
AMRN Amarin Corp Plcuk	$4.24B	$1.08 Million 0.01% of portfolio	120,475	Q1 2025 Added 666.14%
CPRX Catalyst Pharmaceuticals, Inc.	$2.45B	$1.06 Million 0.01% of portfolio	43,755	Q1 2025 Added 3,337.16%
CRMD Cor Medix Inc.	$435M	$983,000 0.01% of portfolio	159,637	Q1 2025 Added 6.54%
ALT Altimmune, Inc.	$278M	$746,000 0.01% of portfolio	149,209	Q1 2025 Added 431.94%
EXEL Exelixis, Inc.	$14.9B	$418,000 0.0% of portfolio	11,339	Q1 2025 Added 60.84%
UTHR United Therapeutics Corp	$13.8B	$328,000 0.0% of portfolio	1,065	Q1 2025 Added 57.78%
ALNY Alnylam Pharmaceuticals, Inc.	$34.9B	$286,000 0.0% of portfolio	1,062	Q1 2025 Added 12.98%
RXRX Recursion Pharmaceuticals, Inc.	$767M	$269,000 0.0% of portfolio	50,865	Q1 2025 Added 249.23%
RPRX Royalty Pharma PLC	$14.5B	$238,000 0.0% of portfolio	7,662	Q1 2025 Added 72.92%
BPMC Blueprint Medicines Corp	$5.94B	$231,000 0.0% of portfolio	2,610	Q4 2024 Reduced 22.11%
ARGX Argenx Se	$31.1B	$220,000 0.0% of portfolio	372	Q1 2025 Reduced 2.11%
BGNE Bei Gene, Ltd.	$23.5B	$160,000 0.0% of portfolio	707	Q4 2024 Added 1.14%
SMMT Summit Therapeutics Inc.	$5.11B	$153,000 0.0% of portfolio	7,976	Q1 2025 Added 218.66%
ETNB 89bio, Inc.	$386M	$150,000 0.0% of portfolio	20,760	Q1 2025 Added 2.72%
IMMP Immutep LTD	$183M	$107,000 0.0% of portfolio	61,000	Q1 2025 New
TECH Bio Techne Corp	$1.89B	$105,000 0.0% of portfolio	1,801	Q1 2025 Reduced 15.72%
BMRN Biomarin Pharmaceutical Inc	$10.8B	$98,000 0.0% of portfolio	1,396	Q1 2025 Reduced 7.3%
ETON Eton Pharmaceuticals, Inc.	$423M	$97,000 0.0% of portfolio	7,499	Q1 2025 New
MIRM Mirum Pharmaceuticals, Inc.	$1.66B	$92,000 0.0% of portfolio	2,050	Q1 2025 Reduced 26.79%
RCKT Rocket Pharmaceuticals, Inc.	$509M	$75,000 0.0% of portfolio	11,340	Q1 2025 Added 69.25%
MRNA Moderna, Inc.	$9.25B	$74,000 0.0% of portfolio	2,615	Q1 2025 Reduced 17.3%
LQDA Liquidia Corp	$1.01B	$73,000 0.0% of portfolio	5,000	Q4 2024 New
MNKD Mannkind Corp	$1.17B	$63,000 0.0% of portfolio	12,627	Q4 2024 Reduced 53.97%
TRVI Trevi Therapeutics, Inc.	$386M	$62,000 0.0% of portfolio	10,000	Q1 2025 New
RARE Ultragenyx Pharmaceutical Inc.	$2.44B	$61,000 0.0% of portfolio	1,710	Q4 2024 Added 2.09%
INSM Insmed Inc	$9.11B	$57,000 0.0% of portfolio	753	Q1 2025 Added 82.32%
ADMA Adma Biologics, Inc.	$3.9B	$54,000 0.0% of portfolio	2,750	Q1 2025 Added 21.57%
INCY Incyte Corp	$14B	$49,000 0.0% of portfolio	812	Q1 2025 Reduced 6.77%
CRSP Crispr Therapeutics Ag	$2.83B	$49,000 0.0% of portfolio	1,440	Q1 2025 Added 67.25%
ARDX Ardelyx, Inc.	$852M	$47,000 0.0% of portfolio	9,728	Q1 2024 Added 462.96%
BBIO Bridge Bio Pharma, Inc.	$5B	$35,000 0.0% of portfolio	1,022	Q4 2024 Added 85.82%
IOVA Iovance Biotherapeutics, Inc.	$278M	$35,000 0.0% of portfolio	10,579	Q1 2025 Reduced 43.36%
HALO Halozyme Therapeutics, Inc.	$6.82B	$34,000 0.0% of portfolio	544	Q1 2025 Added 8.8%
IONS Ionis Pharmaceuticals Inc	$4.68B	$32,000 0.0% of portfolio	1,090	Q1 2025 Reduced 64.54%
BNTX Bio N Tech Se	$22.4B	$25,000 0.0% of portfolio	275	Q1 2025 Reduced 35.29%
ORMP Oramed Pharmaceuticals Inc.	$87.7M	$18,000 0.0% of portfolio	8,826	Q1 2024 New
SRPT Sarepta Therapeutics, Inc.	$3.09B	$17,000 0.0% of portfolio	272	Q1 2025 Reduced 12.82%
IBRX Immunity Bio, Inc.	$1.07B	$15,000 0.0% of portfolio	5,276	Q4 2024 Added 5,176.0%
RLAY Relay Therapeutics, Inc.	$335M	$15,000 0.0% of portfolio	6,100	Q1 2025 Reduced 6.15%
XLO Xilio Therapeutics, Inc.	$19.2M	$14,000 0.0% of portfolio	20,000	Q3 2024 New
ABUS Arbutus Biopharma Corp	$462M	$13,000 0.0% of portfolio	4,000	Q4 2022 Reduced 20.0%
JAZZ Jazz Pharmaceuticals PLC	$6.65B	$13,000 0.0% of portfolio	108	Q4 2024 Reduced 66.97%
TBPH Theravance Biopharma, Inc.	$610M	$13,000 0.0% of portfolio	1,500	Q1 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.